Vasotec Related Published Studies
Well-designed clinical trials related to Vasotec (Enalapril)
Effects of enalapril/lercanidipine combination on some emerging biomarkers in
cardiovascular risk stratification in hypertensive patients. [2014]
Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial. [2011.08]
Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial. [2011.07]
Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial. [2011.01]
Effect of combined spironolactone-beta-blocker +/- enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). [2010.12.01]
Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril. [2010.11]
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. [2010.11]
The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure. [2010.09.24]
Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease. [2010.09]
Enalapril in infants with single ventricle: results of a multicenter randomized trial. [2010.07.27]
A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. [2010.07.01]
A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. [2010.07]
Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study. [2010.06]
A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients. [2010.03]
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease. [2010.03]
Is systemic inflammation of hemodialysis patients improved with the use of enalapril? Results of a randomized, double-blinded, placebo-controlled clinical trial. [2010.01]
Enalapril in infants with single ventricle: results of a multicenter randomized
trial. [2010]
A randomized double-blind trial of enalapril in older patients with heart failure
and preserved ejection fraction: effects on exercise tolerance and arterial
distensibility. [2010]
Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study. [2009.11]
Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease. [2009.10]
[Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level] [2009.08.18]
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients. [2009.08]
Renal and retinal effects of enalapril and losartan in type 1 diabetes. [2009.07.02]
Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial. [2009.06]
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. [2009.04]
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy. [2009.04]
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril. [2009.03]
Combination of amlodipine and enalapril in hypertensive patients with coronary disease. [2009.03]
Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial infarction. [2009]
Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention. [2008.12]
Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis. [2008.12]
[The effect of baseline homocysteine level on the efficacy of enalapril maleate and folic acid tablet in lowering blood pressure and plasma homocysteine] [2008.11.18]
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.11]
Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. [2008.10]
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. [2008.10]
Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. [2008.09]
[Treatment of chronic allograft nephropathy with combination of enalapril and bailing capsule] [2008.09]
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial. [2008.07.23]
Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic Peptide in patients with chronic heart failure. [2008.05]
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. [2008.03]
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. [2008.02]
Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy. [2008]
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. [2007.10.01]
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. [2007.10]
The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. [2007.10]
Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril. [2007.05]
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. [2007.04.17]
Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. [2007.03]
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition. [2007.02]
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. [2007.01]
Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population. [2006.10]
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes. [2006.08]
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. [2006.07]
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study. [2006.06]
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. [2006.05]
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. [2006.04]
Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. [2006.03]
[Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure] [2006.01]
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. [2006.01]
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study. [2006]
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. [2005.11]
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. [2005.10.18]
Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction. [2005.10]
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. [2005.09.01]
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation. [2005.09]
[Double blind study of the efficacy and safety of the fixed dose combination of enalapril 10 mg/nitrendipine 20 mg versus the increase of amlopidine dose in essential hypertensive patients not controlled with amlodipine 5 mg] [2005.09]
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study. [2005.08]
Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. [2005.08]
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. [2005.08]
Incidence and characteristics of angioedema associated with enalapril. [2005.07.25]
Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. [2005.07.01]
Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertension. [2005.07]
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. [2005.04]
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. [2005.04]
Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. [2005.04]
Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril. [2005.03]
[Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life] [2005.03]
Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. [2005.02]
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. [2005.02]
Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis. [2005]
Well-designed clinical trials possibly related to Vasotec (Enalapril)
Identifying differential responders and their characteristics in clinical trials:
innovative methods for analyzing longitudinal data. [2013]
Pharmacokinetics, pharmacodynamics, and tolerability of ACT-077825, a new direct
renin inhibitor after multiple-ascending doses in healthy subjects. [2013]
Entry-into-humans study with a new direct renin inhibitor. [2012]
Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial. [2011.11.16]
Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. [2011.11]
Pharmacotherapy review of chronic pediatric hypertension. [2011.10]
Effect of Chinese herbal medicine for calming Gan () and suppressing hyperactive yang on arterial elasticity function and circadian rhythm of blood pressure in patients with essential hypertension. [2011.06]
Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. [2011.05.31]
Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. [2011.02]
FGF-23 as a predictor of renal outcome in diabetic nephropathy. [2011.02]
Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. [2011.01]
Direct renin inhibition in addition to or as an alternative to angiotensin
converting enzyme inhibition in patients with chronic systolic heart failure:
rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with
HEart failuRE (ATMOSPHERE) study. [2011]
Risk of arrhythmic and nonarrhythmic death in patients with heart failure and
chronic kidney disease. [2011]
Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study. [2010.12.16]
Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction. [2010.12]
Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without beta-blockers. [2010.11]
Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans. [2010.10]
Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension. [2010.09]
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. [2010.08]
Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. [2010.07.23]
|
